Non-alcoholic fatty liver disease physical examination
|
Non-Alcoholic Fatty Liver Disease Microchapters |
|
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case studies |
|
Non-alcoholic fatty liver disease physical examination On the Web |
|
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease physical examination |
|
FDA on Non-alcoholic fatty liver disease physical examination |
|
CDC on Non-alcoholic fatty liver disease physical examination |
|
Non-alcoholic fatty liver disease physical examination in the news |
|
Blogs on Non-alcoholic fatty liver disease physical examination |
|
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
|
Risk calculators and risk factors for Non-alcoholic fatty liver disease physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]Parth Vikram Singh, MBBS[3]
Overview
Patients with NAFLD usually appear asymptomatic. Physical examination of patients with NAFLD is usually unremarkable.
Physical Examination
Patients with NAFLD usually appear asymptomatic. Physical examination of patients with NAFLD is usually unremarkable.[1]
Approximately 50% to 60% of patients with MASLD have mild to moderate hepatomegaly, while less than 5% have splenomegaly. More than 80% of patients are overweight or obese, 60% to 70% have atherogenic dyslipidemia, approximately 60% have prediabetes or type 2 diabetes, and up to 50% have hypertension.[2]
References
- ↑ "Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician".
- ↑ Tilg H, Petta S, Stefan N, Targher G (January 2026). "Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review". JAMA. 335 (2): 163–174. doi:10.1001/jama.2025.19615. PMID 41212550 Check
|pmid=value (help).